Delivery of endostatin in experimental cancer therapy

被引：0
|
作者：
Sorensen, DR [1 ]
Read, TA
机构：
[1] Univ Oslo, Rikshosp, Dept Comparat Med, N-0027 Oslo, Norway
[2] Univ Bergen, Dept Anat & Cell Biol, N-5020 Bergen, Norway
来源：
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY | 2002年 / 83卷 / 06期
关键词：
cancer; delivery; endostatin;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Endostatin, the 20 kDa C-terminal fragment of collagen XVIII, has been shown to be an effective inhibitor of tumour angiogenesis and growth in different experimental systems and is currently in Phase II/III clinical trials. One challenging aspect of anti-angiogenic treatment is the mode of delivery of the active compound. In this paper we review some of the basic knowledge of endostatin and look specifically into the different possible ways in which endostatin may be administered.
引用
收藏
页码：265 / 274
页数：10
相关论文
共 50 条
  • [41] Nonviral Delivery for Genomic Therapy of Cancer
    Nancy Smyth Templeton
    World Journal of Surgery, 2009, 33 : 685 - 697
  • [42] Oral delivery of RNAi for cancer therapy
    Humayra Afrin
    Renu Geetha Bai
    Raj Kumar
    Sheikh Shafin Ahmad
    Sandeep K. Agarwal
    Md Nurunnabi
    Cancer and Metastasis Reviews, 2023, 42 : 699 - 724
  • [43] Targeted drug delivery in cancer therapy
    Vasir, JK
    Labhasetwar, V
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (04) : 363 - 374
  • [44] Nonviral Delivery for Genomic Therapy of Cancer
    Templeton, Nancy Smyth
    WORLD JOURNAL OF SURGERY, 2009, 33 (04) : 685 - 697
  • [45] Nanotechnology for the delivery of phytochemicals in cancer therapy
    Xie, Jing
    Yang, Zhaogang
    Zhou, Chenguang
    Zhu, Jing
    Lee, Robert J.
    Teng, Lesheng
    BIOTECHNOLOGY ADVANCES, 2016, 34 (04) : 343 - 353
  • [46] Advances in siRNA delivery in cancer therapy
    Singh, Aishwarya
    Trivedi, Piyush
    Jain, Narendra Kumar
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (02) : 274 - 283
  • [47] Vinorelbine and cisplatin combined with endostatin as the first-line therapy for metastatic pancreatic cancer
    Dong-Min Chang
    Journal of Pharmaceutical Analysis, 2010, 22 (01) : 69 - 71
  • [48] Vinorelbine and cisplatin combined with endostatin as the first-line therapy for metastatic pancreatic cancer
    DongMin ChangCan ZhouYong ZhangDeQiang ChenGang MaFeng Cao Department of Surgical Oncologythe First Affiliated HospitalMedical School of Xian Jiaotong UniversityXian China
    Academic Journal of Xi'an Jiaotong University, 2010, 22 (01) : 69 - 71
  • [49] Generation of expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy
    Indraccolo, S
    Minuzzo, S
    Gola, E
    Habeler, W
    Carrozzino, F
    Noonan, D
    Albini, A
    Santi, L
    Amadori, A
    Chieco-Bianchi, L
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (04): : 251 - 256
  • [50] Oral delivery of RNAi for cancer therapy
    Afrin, Humayra
    Geetha Bai, Renu
    Kumar, Raj
    Ahmad, Sheikh Shafin
    Agarwal, Sandeep K.
    Nurunnabi, Md
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 699 - 724
12345